Natural History of Ocular GVHD

目前尚无关于该方案的数据可供报告。 到目前为止，已经招募了10名受试者，第一名参与者在自体干细胞移植后刚刚完成一年的检查。 建议几名患者开始外用环孢素滴眼液，以应对眼部指标的变化（症状、泪液分泌下降或表面干燥恶化）。 我们的团队希望将患者症状和检查结果的变化与泪液生物标志物的变化相关联，并希望在下一个报告期内获得初步结果。

There are no data yet to report on this protocol. To date, ten subjects have been enrolled, with the first participant just reaching the one-year exam following autologous stem cell transplant. Several patients were advised to initiate topical cyclosporine eye drops in response to changes in ocular indicators (symptoms, drop in Schirmers tear production, or worsening of surface dryness). Our team hopes to correlate changes in patient symptoms and exam findings with changes in the tear fluid biomarkers, and expects to have initial results by the next reporting period.